![]() |
International Journal of Bioelectromagnetism Vol. 5, No. 1, p. 300, 2003. |
www.ijbem.org |
|
Nonlinear Dynamics of Heart Rate and Repolarization Juha S. Perkiömäki Division of Cardiology, Department of Internal Medicine, University of Oulu, Oulu, Finland Abstract. Several methods of heart
rate variability have been used to describe different components of the complex
regulatory system between heart rate and the autonomic nervous system. Conventionally,
heart rate variability has been analyzed with time- and frequency-domain methods.
Recently, there has been growing interest in nonlinear methods of heart rate
variability as these methods may reveal more delicate changes in heart rate
dynamics than the conventional heart rate variability measurements. These
nonlinear methods of heart rate variability assess quality properties rather
than the magnitude of the signal. Several types of different fractal scaling
measures, power-law analyses, complexity measures and symbolic measures have
been tested in various patient populations. Methods of analyzing the fractal-like
scaling properties and the complexity of the RR interval time series are the
nonlinear heart rate variability measures that are most widely studied in
clinical settings. In a few recent studies, some of these newer nonlinear
measures of heart rate variability have been suggested to be better predictors
of mortality than traditional methods. The power-law slope describing long-term
fractal-like heart rate behavior has been found to be a better predictor of
mortality in the elderly than the conventional measures. More negative values
of the power-law slope have been shown to be associated with increased mortality
and to precede the spontaneous onset of ventricular fibrillation in postinfarction
patients. Altered short-term fractal-like properties of heart rate fluctuations
have been observed to have better prognostic power than conventional heart
rate variability measures among survivors of acute myocardial infarction with
decreased left ventricular function. Furthermore, reduced short-term fractal-like
scaling exponent values have been found to be associated with mortality in
patients with heart failure. Recent observations in a relatively small group
of high-risk patients with implantable cardioverter-defibrillators have shown
that the short-term scaling exponent obtained from short-term 10-minute electrocardiographic
recordings yields important prognostic information. The short-term scaling
exponent has also been suggested to be a powerful predictor of cardiac mortality
in the elderly. Reduced approximate entropy values indicating larger predictability
and decreased complexity in heart rate behavior have been reported to precede
spontaneous episodes of atrial fibrillation in patients after coronary artery
bypass surgery and in patients without structural heart disease. Patients
with postoperative complications after cardiac surgery have also been observed
to have decreased complexity in heart rate dynamics. It has been suggested
that the autonomic nervous influences on ventricular repolarization duration
and heart rate are qualitively similar in normal individuals, but may be dissimilar
in pathological conditions. Repolarization variability has been found to be
increased in patients with ischemic and nonischemic dilated and hypertrophic
cardiomyopathies as well as in patients with the congenital long QT syndrome.
However, data on the nonlinear dynamics of repolarization are very limited.
Recent observations suggest that increased temporal complexity of repolarization
measured by approximate entropy independently predicts mortality in high risk
patients with decreased left ventricular function and implantable cardioverter-defibrillators.
None of the temporal repolarization variability parameters determined by traditional
statistical measures of variance were associated with adverse events in these
patients. Different kind of alterations in nonlinear dynamics of repolarization
than in nonlinear dynamics of heart rate are related to risk for mortality
in high risk patients with reduced left ventricular function and implantable
cardioverter-defibrillators.
|